Article - BioPharm International

ADVERTISEMENT

Article

Scalability of the Mobius CellReady Single-use Bioreactor Systems

April 2, 2013

Review the process-design space and scalability of a single-use, stirred-tank bioreactor.

Custom-Cell Products: Diversified In Vitro Models

April 1, 2013

The author outlines the need for custom-cell products.

Translating Stem Cells From Laboratory to Clinic

April 1, 2013

Ontario-area scientists discuss approaches to development of stem-cell therapies.

Analytical Method Lifecycle: A Roadmap for Biopharmaceutical Development

April 1, 2013

The authors propose a roadmap for analytical lifecycle development.

Increasing Lyophilization Productivity, Flexibility, and Reliability Using Liquid Nitrogen Refrigeration–Part 1 of 2

November 1, 2007

Protein Therapeutics and the Regulation of Quality: A Brief History

October 1, 2007

Regulatory agencies have evolved along with the biotechnology industry to define quality standards.

Regulatory Issues: Pandemic Preparedness Pacing Up

August 2, 2007

Any endpoint considered appropriate to support approval, whether a surrogate or a clinical endpoint, must be supported by substantial evidence of effectiveness.

Vaccine Characterization Using Advanced Technology

August 2, 2007

With the advent of high-resolution mass spectrometers and highly sensitive MS instruments, vaccine characterization has entered a new phase.

Cancer Vaccines: Asymptotically Approaching Product Approval

August 2, 2007

For many cell-based vaccines, the precursor monocytes or CD34+ cells are cultured with cytokines to obtain dendritic cells, which are very potent antigen-presenting cells (APCs).

ADVERTISEMENT

ADVERTISEMENT

Click here